Skip to Main Content

March 17, 2023    
Health Law Weekly

Sanofi to Acquire Provention Bio for $2.9 Billion

  • March 17, 2023

Sanofi will buy U.S.-based Provention Bio, Inc. for $2.9 billion in a deal that will add to the French pharmaceutical manufacturer's existing diabetes drug portfolio.


You must be logged in to access this content.